Could a shot cure your acne? new mRNA vaccine trial begins

NCT ID NCT07013747

First seen Jun 24, 2026 · Last updated Jul 10, 2026 · Updated 3 times

Summary

This study tests an mRNA vaccine designed to fight acne. Researchers will give two shots to 120 adults aged 18 to 45 with mild acne. The goal is to see if the vaccine is safe and reduces pimples. Participants are randomly assigned to receive the vaccine or a placebo.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Acne mRNA vaccine
What this could lead to
If successful, this could lead to a new way to treat or prevent acne by training the immune system to target acne-causing bacteria.
What could go wrong
This is an early phase 1/2 trial with only 120 participants, so it is too soon to know if it works. The vaccine may cause side effects or fail to improve acne.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • DelRicht Research- Site Number : 8400003

    RECRUITING

    New Orleans, Louisiana, 70115, United States

  • Encino Research Center- Site Number : 8400008

    RECRUITING

    Encino, California, 91436, United States

  • Encore Research Group-Jacksonville Center for Clinical Research- Site Number : 8400006

    RECRUITING

    Jacksonville, Florida, 32216, United States

  • Moore Clinical Research - Brandon- Site Number : 8400007

    RECRUITING

    Brandon, Florida, 33511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.